As state legislatures begin to convene their sessions in 2025, several key issues related to rheumatology are expected to take center stage, including drug costs, utilization management, telehealth and copay accumulators.
Unless Congress Acts, Medicare Reimbursement Will Remain Flat or Drop in 2025
The 2025 Medicare Physician Fee Schedule final rule, released Nov. 1, includes a conversion factor of $32.3465, a 2.83% drop from 2024. In response to advocacy efforts from the ACR and other medical societies, Congress recently introduced the Medicare Patient Access and Practice Stabilization Act of 2024, which would eliminate the 2.83% payment cut and provide an inflationary update for 2025 equal to 50% of the Medicare Economic Index.
2024 Election Summary, Outlook for the Lame Duck Session & the New Congress
With a likely Republican majority in the House and Senate and a Republican president, there may be a sense that the party has a mandate to lead initiatives and enact significant policy changes. Any end-of-year legislative package will be narrower than initially expected, but the ACR’s top priority remains addressing cuts to physician reimbursements.
ATAP Board Appointments for 2024-25 Include 2 Distinguished ACR Members
The Alliance for Transparent and Affordable Prescriptions’ board members for the 2024–25 cycle include Marcus Snow, MD, and Howard Blumstein, MD, who both have a strong history of volunteer leadership in the ACR.
Interim AMA House of Delegates Meeting Will Discuss Rheumatology Priorities
At the November meeting, the ACR will advance a resolution that addresses increasing access to telemedicine services for Medicare beneficiaries.
Take Action on Medicare Payment, Telehealth
Medicare physician reimbursement and extension of telehealth flexibilities are two of the ACR’s top legislative priorities as Congress approaches the lame duck session. With physicians facing a 2.8% cut under the 2025 Medicare Physician Fee Schedule proposed rule and telehealth flexibilities set to expire at the end of this year, Congress must hear from the…
Ways You Can Be a Rheumatology Advocate at ACR Convergence 2024
As you make your plans to attend ACR Convergence 2024, keep in mind that the ACR advocacy team will host several events and programs throughout the week. If you have any questions, get in touch with our team at [email protected]. RheumPAC Lounge & Donor Event Investing in RheumPAC is a great way to support the…
ACR-Led Coalition Working Toward Legislative Solutions for Underwater Biosimilars
The Underwater Biosimilars Coalition will meet with the Medicare Payment Advisory Commission to discuss concerns about inadequate reimbursement for certain biosimilars, which has limited beneficiary access to these lower-cost alternative therapies.
Resources for Practices to Fight Payer Downcoding of E/M Services
The American Medical Association and ACR Insurance Subcommittee offer support and guidance to help practices recognize and push back against downcoded payments for evaluation and management services.
Congressional Action Needed to Maintain Medicare’s Extended Telehealth Services
Medicare’s extended telehealth services will expire at the end of the year unless Congress acts to continue them. Make sure your legislators know how a failure to act will harm patient access to care.
- 1
- 2
- 3
- …
- 85
- Next Page »